Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Cash & Current Investments: 2010-2012

Historic Cash & Current Investments for Sonoma Pharmaceuticals (SNOA) over the last 3 years, with Dec 2012 value amounting to $6.6 million.

  • Sonoma Pharmaceuticals' Cash & Current Investments rose 33.00% to $6.6 million in Q4 2012 from the same period last year, while for Dec 2012 it was $22.7 million, marking a year-over-year increase of 26.02%. This contributed to the annual value of $3.4 million for FY2012, which is 23.34% down from last year.
  • According to the latest figures from Q4 2012, Sonoma Pharmaceuticals' Cash & Current Investments is $6.6 million, which was down 20.60% from $8.3 million recorded in Q3 2012.
  • In the past 5 years, Sonoma Pharmaceuticals' Cash & Current Investments ranged from a high of $8.3 million in Q3 2012 and a low of $3.4 million during Q1 2012.
  • Moreover, its 3-year median value for Cash & Current Investments was $5.0 million (2011), whereas its average is $5.2 million.
  • As far as peak fluctuations go, Sonoma Pharmaceuticals' Cash & Current Investments slumped by 32.51% in 2011, and later skyrocketed by 129.43% in 2012.
  • Quarterly analysis of 3 years shows Sonoma Pharmaceuticals' Cash & Current Investments stood at $4.7 million in 2010, then rose by 6.16% to $5.0 million in 2011, then soared by 33.00% to $6.6 million in 2012.
  • Its Cash & Current Investments was $6.6 million in Q4 2012, compared to $8.3 million in Q3 2012 and $4.4 million in Q2 2012.